CCM
CNSP icon

Connective Capital Management’s CNS Pharmaceuticals CNSP Stock Holding History

Connective Capital Management’s Portfolio CNSP Stock Details CNSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-467
Closed -$33.7K – 57
2024
Q4 		$33.7K Buy
+467
New +$33.2K 0.04% 57

Other funds holding CNSP

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BC
Barrett & Company Providence, Rhode Island $357M AUM 22.45% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Connective Capital Management's CNSP Position: Q1 2025 in Review

Connective Capital Management sold out of CNS Pharmaceuticals (CNSP) in Q1 2025, closing a stake of 467 shares — an estimated $33.7K sold.

Connective Capital Management first reported a position in CNSP in Q4 2024 and held it in 1 quarter. The position peaked at $33.7K in Q4 2024. 7 funds tracked by Wall St. Rank hold CNSP as of Q1 2025.

  • Connective Capital Management reported no remaining CNS Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Connective Capital Management sold 467 CNS Pharmaceuticals shares in Q1 2025, an estimated $33.7K.
  • Connective Capital Management first reported a position in CNS Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Connective Capital Management's CNS Pharmaceuticals position peaked at $33.7K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q1 2025.

Based on Connective Capital Management's 13F filing for Q1 2025, filed 14 May 2025.